Cardlytics, Inc. (NASDAQ:CDLX – Get Free Report) CFO Alexis Desieno sold 7,487 shares of the company’s stock in a transaction dated Wednesday, October 2nd. The stock was sold at an average price of $3.08, for a total transaction of $23,059.96. Following the completion of the sale, the chief financial officer now directly owns 97,849 shares in the company, valued at $301,374.92. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink.
Cardlytics Stock Up 7.5 %
Cardlytics stock opened at $3.29 on Friday. Cardlytics, Inc. has a 12 month low of $2.89 and a 12 month high of $20.52. The stock has a fifty day simple moving average of $4.35 and a two-hundred day simple moving average of $8.52. The company has a current ratio of 1.77, a quick ratio of 1.77 and a debt-to-equity ratio of 1.01. The firm has a market cap of $160.50 million, a price-to-earnings ratio of -0.74 and a beta of 1.67.
Cardlytics (NASDAQ:CDLX – Get Free Report) last released its quarterly earnings data on Wednesday, August 7th. The company reported ($0.09) earnings per share for the quarter, beating the consensus estimate of ($0.21) by $0.12. The firm had revenue of $69.64 million during the quarter, compared to analysts’ expectations of $75.39 million. Cardlytics had a negative net margin of 50.21% and a negative return on equity of 17.96%. The firm’s quarterly revenue was down 9.2% on a year-over-year basis. During the same period in the previous year, the company earned ($0.57) earnings per share. Equities analysts predict that Cardlytics, Inc. will post -1.72 EPS for the current fiscal year.
Institutional Investors Weigh In On Cardlytics
Wall Street Analysts Forecast Growth
CDLX has been the topic of several research reports. Needham & Company LLC lowered shares of Cardlytics from a “buy” rating to a “hold” rating in a research note on Thursday, August 8th. Northland Securities downgraded Cardlytics from an “outperform” rating to a “market perform” rating and cut their price target for the stock from $7.00 to $5.00 in a research note on Friday, August 16th. Lake Street Capital lowered Cardlytics from a “buy” rating to a “hold” rating and reduced their price objective for the company from $18.00 to $5.00 in a research report on Thursday, August 8th. Northland Capmk lowered Cardlytics from a “strong-buy” rating to a “hold” rating in a research report on Friday, August 16th. Finally, Bank of America downgraded shares of Cardlytics from a “neutral” rating to an “underperform” rating and cut their price objective for the company from $4.00 to $3.50 in a research report on Thursday, August 15th. One investment analyst has rated the stock with a sell rating and five have issued a hold rating to the company’s stock. According to MarketBeat.com, the stock has a consensus rating of “Hold” and an average price target of $7.50.
Read Our Latest Report on CDLX
About Cardlytics
Cardlytics, Inc operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data and enables marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing.
Read More
- Five stocks we like better than Cardlytics
- What Are Trending Stocks? Trending Stocks Explained
- The Outlook for Interest Rate Cuts Got Blown Out of the Water
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- 3 High-Risk, High-Reward Micro-Cap Stocks You Shouldn’t Ignore
- Roth IRA Calculator: Calculate Your Potential Returns
- 3 Bargain Stocks Positioned for Gains After Missing 2024’s Rally
Receive News & Ratings for Cardlytics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardlytics and related companies with MarketBeat.com's FREE daily email newsletter.